Literature DB >> 6873139

Biotransformation of amitriptyline in alcoholic depressive patients.

M Sandoz, S Vandel, B Vandel, B Bonin, G Allers, R Volmat.   

Abstract

The biotransformation of amitriptyline (AMT) during steady state conditions was studied in plasma and urine from 11 nonalcoholic and 10 alcoholic depressive inpatients treated with oral AMT. The 2 groups of patients had a different pattern of biotransformation. The Demethylation of AMT was lower in alcoholic than in nonalcoholic depressive patients, and conjugation and hydroxylation of AMT were also more marked in the former group. The results may be of clinical relevance since the conjugates of AMT are inactive.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873139     DOI: 10.1007/bf00542210

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  39 in total

1.  Mechanism of the effect of acute ethanol on hexobarbital metabolism.

Authors:  H Chung; D R Brown
Journal:  Biochem Pharmacol       Date:  1976-07-15       Impact factor: 5.858

2.  Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline.

Authors:  S Vandel; B Vandel; M Sandoz; G Allers; P Bechtel; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

3.  Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man.

Authors:  L F Gram; K Overo; L Kirk
Journal:  Am J Psychiatry       Date:  1974-08       Impact factor: 18.112

4.  Studies of human urinary and biliary metabolites of nortriptyline with stable isotope labeling.

Authors:  D R Knapp; T E Gaffney; R E McMahon; G Kiplinger
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030

5.  Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolites.

Authors:  B Vandel; M Sandoz; S Vandel; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Determination of amitriptyline and its major basic metabolites in human urine by high-performance liquid chromatography.

Authors:  S R Biggs; L F Chasseaud; D R Hawkins; I Midgley
Journal:  Drug Metab Dispos       Date:  1979 Jul-Aug       Impact factor: 3.922

7.  Drug metabolism in heavy consumers of ethyl alcohol.

Authors:  F L Iber
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

8.  [Alcohol-psychotropic drug interactions].

Authors:  J P Boulenger; S Brion
Journal:  Encephale       Date:  1976       Impact factor: 1.291

9.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

Review 10.  Drug interactions with alcohol.

Authors:  M Linnoila; M J Mattila; B S Kitchell
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

View more
  3 in total

Review 1.  Discrepancies between pharmacokinetic studies of amitriptyline.

Authors:  P Schulz; P Dick; T F Blaschke; L Hollister
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

2.  Metabolism of amitriptyline in patients with chronic renal failure.

Authors:  M Sandoz; S Vandel; B Vandel; B Bonin; B Hory; Y St Hillier; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  Drug administration in chronic liver disease.

Authors:  J F Westphal; J M Brogard
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.228

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.